Adagio Medical Holdings (ADGM) Capital Expenditures (2023 - 2026)
Adagio Medical Holdings (ADGM) reported Capital Expenditures of $2000.0 for Q1 2026, down 99.4% on a YoY basis from $335000.0 in Q1 2025, and up 100.41% sequentially from -$491000.0 in Q4 2025.
Adagio Medical Holdings (ADGM) Capital Expenditures (2023 - 2026) Analysis & Trends
Adagio Medical Holdings (ADGM) has 4 years of Capital Expenditures data on file, last reported at $2000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 99.4% year-over-year to $2000.0; the trailing twelve-month figure through Mar 2026 stood at $424000.0 (down 60.63% YoY), and the FY2025 full-year result was $374000.0, down 70.78% from the prior year.
- Capital Expenditures climbed to $2000.0 in Q1 2026, from -$491000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $578000.0 in Q3 2024 to a low of -$491000.0 in Q4 2025.
- A 4-year average of $40285.7 and a median of $2000.0 in 2024 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures surged 106.79% in 2025 and sank 99.4% in 2026, its largest moves.
- Tracing ADGM's Capital Expenditures over 4 years: stood at -$306000.0 in 2023, then jumped by 288.89% to $578000.0 in 2024, then plunged by 184.95% to -$491000.0 in 2025, then soared by 100.41% to $2000.0 in 2026.
- Business Quant data shows ADGM's Capital Expenditures at $2000.0 in Q1 2026, -$491000.0 in Q4 2025, and $335000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Adagio Medical Holdings | 21.49 Mn | 21.49 Mn | - | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | -491,000.00 |
| Dec 31, 2025 | -491,000.00 |
| Mar 31, 2025 | 335,000.00 |
| Mar 31, 2025 | 335,000.00 |
| Sep 30, 2024 | 578,000.00 |
| Sep 30, 2024 | 578,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 162,000.00 |
| Mar 31, 2024 | 162,000.00 |
| Dec 31, 2023 | -306,000.00 |
| Dec 31, 2023 | -306,000.00 |